Custom oligo synthesis. Quote#2010-13907.ambis#937255THIS is a standing order . Our lab has a high demand/usage level for oligonucleotides, since we use these for virtually every project- particularly…
Ended Awarded Last action
- Contract number
- HHSN27200015
- Awardee
-
Bio-Synthesis, Inc. UEI MWJBT69QFLH4
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,790
Award facts
- Contract value 50% obligated
-
- $14,790.00 Current, with exercised options
- $29,580.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 0 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Economy Act FAR subpart 17.5
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$210 | |
| Original award | $15,000 |
About this award
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Synthesis, Inc. (doing business as Dnaexam) for the custom synthesis of oligonucleotides. The contract has a ceiling value of $29,580.00 and an ultimate completion date of February 28, 2010. The agency indicates a high demand and usage level for these oligonucleotides, particularly for a recombinant vaccine project against retroviruses associated with AIDS. The contract was awarded without a set-aside designation, and the agency determined the price to be fair and reasonable based on the vendor's catalog price list.
Description
Custom oligo synthesis. Quote#2010-13907.ambis#937255THIS is a standing order . Our lab has a high demand/usage level for oligonucleotides, since we use these for virtually every project- particularly project #'S Z01 A1: 00416-14, recominent vacine against retroviruses assocated with aides. This companyhas supplied US with high quality oligonucleotides at a cost well below what we could make them for in our lab on several occasions. Fair and reasonable price is determined. Changing variable would disruptive of experimentin progress far 6-302-1. Fair and reasonable price based on catalog price list on file.
Quick answers
Who was awarded contract HHSN27200015?
HHSN27200015 was awarded to Bio-Synthesis, Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on January 27, 2010.
How much is contract HHSN27200015 worth?
The government has obligated $14,790 on HHSN27200015. Its potential value, with all options, is $29,580.
Is contract HHSN27200015 an order under another contract?
Yes. HHSN27200015 is a BPA call under HHSN263199900050713B, a blanket purchase agreement.
Was contract HHSN27200015 competed?
The extent of competition for HHSN27200015 was competed under sap. The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award